Management of Generalized Granuloma Annulare Using Systemic Biologics and Small Molecules: An Evidence-Based Review

J Cutan Med Surg. 2024 Nov-Dec;28(6):612-613. doi: 10.1177/12034754241285567. Epub 2024 Oct 5.

Authors

Siddhartha Sood¹, Ahmed Bagit¹, Aswen Sriranganathan², Khalad Maliyar³, Muskaan Sachdeva³, Abrahim Abduelmula³, Yuliya Lytvyn³, Asfandyar Mufti^{3

4}, Jensen Yeung^{3

4

5

6}

Affiliations

¹ Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁴ Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁵ Probity Medical Research, Waterloo, ON, Canada.
⁶ Department of Dermatology, Women's College Hospital, Toronto, ON, Canada.

PMID: 39367794
DOI: 10.1177/12034754241285567

No abstract available

Keywords: Janus kinase inhibitor; biologic; granuloma annulare; small molecule; systematic review.

Publication types

Letter